On the public citation graph

Virtual Screening of Novel Noncovalent Inhibitors for SARS-CoV 3C-like Proteinase

https://doi.org/10.1021/ci049809b
0 signed · 97 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ptr.1397openalex-snapshot
Is traditional Chinese medicine useful in the treatment of SARS?
inferredcites →https://doi.org/10.1006/jmbi.1993.1636openalex-snapshot
Hepatitis A Virus 3C Proteinase: Some Properties, Crystallization and Preliminary Crystallographic Characterization
inferredcites →https://doi.org/10.1007/s0089400060498openalex-snapshot
LigBuilder: A Multi-Purpose Program for Structure-Based Drug Design
inferredcites →https://doi.org/10.1007/s008940050096openalex-snapshot
SCORE: A New Empirical Method for Estimating the Binding Affinity of a Protein-Ligand Complex
inferredcites →https://doi.org/10.1016/j.bmcl.2003.08.066openalex-snapshot
Identifying inhibitors of the SARS coronavirus proteinase
inferredcites →https://doi.org/10.1016/s0006-291x(03)01342-1openalex-snapshot
Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS
inferredcites →https://doi.org/10.1016/s0140-6736(03)13265-5openalex-snapshot
Development of a standard treatment protocol for severe acute respiratory syndrome
inferredcites →https://doi.org/10.1016/s0140-6736(03)13973-6openalex-snapshot
Treatment of SARS with human interferons
inferredcites →https://doi.org/10.1016/s0166-3542(00)00106-6openalex-snapshot
In vitro activity of pleconaril and AG7088 against selected serotypes and clinical isolates of human rhinoviruses1
inferredcites →https://doi.org/10.1016/s0960-894x(03)00753-4openalex-snapshot
Synthesis and evaluation of tripeptidyl α-Ketoamides as human rhinovirus 3C protease inhibitors
inferredcites →https://doi.org/10.1016/s1359-6446(02)02483-2openalex-snapshot
Structure-based virtual screening: an overview
inferredcites →https://doi.org/10.1021/bi036022qopenalex-snapshot
3C-like Proteinase from SARS Coronavirus Catalyzes Substrate Hydrolysis by a General Base Mechanism
inferredcites →https://doi.org/10.1021/jm034137mopenalex-snapshot
Sabadinine: A Potential Non-Peptide Anti-Severe Acute-Respiratory-Syndrome Agent Identified Using Structure-Aided Design
inferredcites →https://doi.org/10.1021/jo0109016openalex-snapshot
Serine and Threonine β-Lactones: A New Class of Hepatitis A Virus 3C Cysteine Proteinase Inhibitors
inferredcites →https://doi.org/10.1023/a:1011115820450openalex-snapshot
DOCK 4.0: Search strategies for automated molecular docking of flexible molecule databases
inferredcites →https://doi.org/10.1023/a:1011188704521openalex-snapshot
Protein ligand docking based on empirical method for binding affinity estimation
inferredcites →https://doi.org/10.1023/a:1016357811882openalex-snapshot
Further development and validation of empirical scoring functions for structure-based binding affinity prediction
inferredcites →https://doi.org/10.1038/369072a0openalex-snapshot
Picornaviral 3C cysteine proteinases have a fold similar to chymotrypsin-like serine proteinases
inferredcites →https://doi.org/10.1042/bst0300797openalex-snapshot
Virtual screening: a real screening complement to high-throughput screening
inferredcites →https://doi.org/10.1056/nejmc031427openalex-snapshot
A Novel Coronavirus and SARS
inferredcites →https://doi.org/10.1056/nejmoa030634openalex-snapshot
Identification of Severe Acute Respiratory Syndrome in Canada
inferredcites →https://doi.org/10.1056/nejmoa030685openalex-snapshot
A Major Outbreak of Severe Acute Respiratory Syndrome in Hong Kong
inferredcites →https://doi.org/10.1056/nejmp030078openalex-snapshot
SARS-Associated Coronavirus
inferredcites →https://doi.org/10.1073/pnas.1835675100openalex-snapshot
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
inferredcites →https://doi.org/10.1073/pnas.96.20.11000openalex-snapshot
Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
inferredcites →https://doi.org/10.1074/jbc.m310875200openalex-snapshot
Biosynthesis, Purification, and Substrate Specificity of Severe Acute Respiratory Syndrome Coronavirus 3C-like Proteinase
inferredcites →https://doi.org/10.1086/378304openalex-snapshot
Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada
inferredcites →https://doi.org/10.1093/emboj/cdf327openalex-snapshot
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra α‐helical domain
inferredcites →https://doi.org/10.1126/science.1085658openalex-snapshot
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
inferredcites →https://doi.org/10.1126/science.1085952openalex-snapshot
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
inferredcites →https://doi.org/10.1128/aac.44.5.1236-1241.2000openalex-snapshot
Inhibition of Human Rhinovirus-Induced Cytokine Production by AG7088, a Human Rhinovirus 3C Protease Inhibitor
inferredcites →https://doi.org/10.1385/criai:24:2:149openalex-snapshot
Crossreacting Drugs and Chemicals
inferredcites →https://doi.org/10.2165/00002018-199513040-00003openalex-snapshot
Comparative Adverse Effect Profiles of Platinum Drugs
inferredcites →https://doi.org/10.2306/scienceasia1513-1874.2003.29.181openalex-snapshot

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.1002/0470037237.ch16openalex-snapshot
Success Stories of Computer‐Aided Design
inferred← citeshttps://doi.org/10.1002/0471266949.bmc140openalex-snapshot
Docking and Scoring in Drug Discovery
inferred← citeshttps://doi.org/10.1002/9781118733103.ch15openalex-snapshot
Virtual screening and prediction of the molecular mechanism of bioactive compounds in silico
inferred← citeshttps://doi.org/10.1002/9783527633326.ch14openalex-snapshot
Virtual Screening on Homology Models
inferred← citeshttps://doi.org/10.1002/chin.200515222openalex-snapshot
Virtual Screening of Novel Noncovalent Inhibitors for SARS‐CoV 3C‐Like Proteinase.
inferred← citeshttps://doi.org/10.1002/cmdc.202000223openalex-snapshot
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
inferred← citeshttps://doi.org/10.1002/minf.202100062openalex-snapshot
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS‐CoV‐2: A Combinedin silicoandin vitroStudy
inferred← citeshttps://doi.org/10.1002/prot.21002openalex-snapshot
Minimizing false positives in kinase virtual screens
inferred← citeshttps://doi.org/10.1002/prot.21405openalex-snapshot
Structure‐based virtual ligand screening with LigandFit: Pose prediction and enrichment of compound collections
inferred← citeshttps://doi.org/10.1007/10_2008_35openalex-snapshot
Environmental Biotechnology in China
inferred← citeshttps://doi.org/10.1007/s10096-005-0004-zopenalex-snapshot
Treatment of severe acute respiratory syndrome
inferred← citeshttps://doi.org/10.1007/s40203-025-00336-2openalex-snapshot
Molecular docking, pharmacological profiling, and MD simulations of glycolytic inhibitors targeting novel SARS CoV-2 main protease and spike protein
inferred← citeshttps://doi.org/10.1007/s44371-025-00144-9openalex-snapshot
Synthesis and evaluation of carmofur analogs as antiproliferative agents, inhibitors to the main protease (Mpro) of SARS-CoV-2, and membrane rupture-inducing agents
inferred← citeshttps://doi.org/10.1016/b978-0-12-821748-1.00004-xopenalex-snapshot
Structure- and ligand-based drug design
inferred← citeshttps://doi.org/10.1016/b978-0-443-18638-7.00024-4openalex-snapshot
Computer-aided drug design: An overview
inferred← citeshttps://doi.org/10.1016/j.antiviral.2005.03.002openalex-snapshot
Development of antiviral therapy for severe acute respiratory syndrome
inferred← citeshttps://doi.org/10.1016/j.antiviral.2007.12.005openalex-snapshot
Is the anti-psychotic, 10-(3-(dimethylamino)propyl)phenothiazine (promazine), a potential drug with which to treat SARS infections?
inferred← citeshttps://doi.org/10.1016/j.bbrc.2005.02.061openalex-snapshot
The substrate specificity of SARS coronavirus 3C-like proteinase
inferred← citeshttps://doi.org/10.1016/j.bmc.2006.09.014openalex-snapshot
Binding interaction of quercetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure–activity relationship studies reveal salient pharmacophore features
inferred← citeshttps://doi.org/10.1016/j.bmc.2007.09.034openalex-snapshot
Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro
inferred← citeshttps://doi.org/10.1016/j.bmc.2008.01.011openalex-snapshot
Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
inferred← citeshttps://doi.org/10.1016/j.bmc.2010.09.050openalex-snapshot
Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
inferred← citeshttps://doi.org/10.1016/j.bmc.2012.11.017openalex-snapshot
Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
inferred← citeshttps://doi.org/10.1016/j.bmcl.2005.11.018openalex-snapshot
From genome to drug lead: Identification of a small-molecule inhibitor of the SARS virus
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.04.118openalex-snapshot
Synthesis, docking studies, and evaluation of pyrimidines as inhibitors of SARS-CoV 3CL protease
inferred← citeshttps://doi.org/10.1016/j.ddtec.2006.09.005openalex-snapshot
Techniques used for the discovery of therapeutic compounds: The case of SARS
inferred← citeshttps://doi.org/10.1016/j.drudis.2006.03.009openalex-snapshot
Consensus scoring for protein–ligand interactions
inferred← citeshttps://doi.org/10.1016/j.ejmech.2023.115772openalex-snapshot
Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: A comprehensive review
inferred← citeshttps://doi.org/10.1016/j.ejphar.2020.173781openalex-snapshot
Investigation of beta-lactoglobulin derived bioactive peptides against SARS-CoV-2 (COVID-19): In silico analysis
inferred← citeshttps://doi.org/10.1016/j.jmb.2005.09.004openalex-snapshot
Crystal Structures of the Main Peptidase from the SARS Coronavirus Inhibited by a Substrate-like Aza-peptide Epoxide
inferred← citeshttps://doi.org/10.1016/j.virusres.2007.02.015openalex-snapshot
Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery
inferred← citeshttps://doi.org/10.1016/s0065-7743(06)41011-3openalex-snapshot
Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy
inferred← citeshttps://doi.org/10.1016/s1574-1400(06)02009-3openalex-snapshot
Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR
inferred← citeshttps://doi.org/10.1017/cbo9780511730412.009openalex-snapshot
Docking: a domesday report
inferred← citeshttps://doi.org/10.1021/acs.jcim.0c00326openalex-snapshot
Discovery of New Hydroxyethylamine Analogs against 3CLpro Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure–Activity Relationship Studies
inferred← citeshttps://doi.org/10.1021/ci1004916openalex-snapshot
Inhibitors of SARS-3CL pro : Virtual Screening, Biological Evaluation, and Molecular Dynamics Simulation Studies
inferred← citeshttps://doi.org/10.1021/ci200036mopenalex-snapshot
Automatic Tailoring and Transplanting: A Practical Method that Makes Virtual Screening More Useful
inferred← citeshttps://doi.org/10.1021/jm050852fopenalex-snapshot
Discovery of a Novel Family of SARS-CoV Protease Inhibitors by Virtual Screening and 3D-QSAR Studies
inferred← citeshttps://doi.org/10.1021/jm060207oopenalex-snapshot
Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease
inferred← citeshttps://doi.org/10.1038/sj.bjp.0707306openalex-snapshot
In silicopharmacology for drug discovery: applications to targets and beyond
inferred← citeshttps://doi.org/10.1039/d0ra04395hopenalex-snapshot
Targeting severe acute respiratory syndrome-coronavirus (SARS-CoV-1) with structurally diverse inhibitors: a comprehensive review
inferred← citeshttps://doi.org/10.1080/10629360600884462openalex-snapshot
Collection and preparation of molecular databases for virtual screening
inferred← citeshttps://doi.org/10.1109/access.2020.3008733openalex-snapshot
A Bibliometric Analysis of Corona Pandemic in Social Sciences: A Review of Influential Aspects and Conceptual Structure
inferred← citeshttps://doi.org/10.1128/mmbr.69.4.635-664.2005openalex-snapshot
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
inferred← citeshttps://doi.org/10.1142/s0219633608004155openalex-snapshot
POSE SCALING: GEOMETRICAL ASSESSMENT OF LIGAND BINDING POSES
inferred← citeshttps://doi.org/10.1360/ssc-2020-0145openalex-snapshot
Advances in enzymatic activity regulation mechanism and inhibitor discovery of coronavirus 3C-like protease
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1000020openalex-snapshot
Bioinformatics in China: A Personal Perspective
inferred← citeshttps://doi.org/10.1371/journal.pcbi.1003249openalex-snapshot
Ligand Clouds around Protein Clouds: A Scenario of Ligand Binding with Intrinsically Disordered Proteins
inferred← citeshttps://doi.org/10.1371/journal.pone.0240653openalex-snapshot
Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies
inferred← citeshttps://doi.org/10.14710/jksa.27.7.336-343openalex-snapshot
Virtual Screening of Syzygium cumini (L.) Skeels Flavonoid Compounds as SARS-CoV-2 Main Protease Therapy Candidates
inferred← citeshttps://doi.org/10.1517/13543770802600698openalex-snapshot
Therapies for coronaviruses. Part 2: inhibitors of intracellular life cycle
inferred← citeshttps://doi.org/10.17192/z2007.0753openalex-snapshot
Leitstrukturoptimierung für Antiprotozoika und Erfolgreiche Leitstruktursuche für Metalloproteinasen: Ein Fragment-basiertes Virtuelles Screening Verfahren
inferred← citeshttps://doi.org/10.2174/0122102981273400231220112631openalex-snapshot
Computational Approaches Molecular Docking and MD Simulation Establishes the Potential COVID-19 Main Protease Inhibitors from Natural Products
inferred← citeshttps://doi.org/10.2174/0929867327666200812215852openalex-snapshot
Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections
inferred← citeshttps://doi.org/10.2174/138161206779010369openalex-snapshot
Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
inferred← citeshttps://doi.org/10.2174/1568026620666201207095117openalex-snapshot
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors
inferred← citeshttps://doi.org/10.26434/chemrxiv.12032712openalex-snapshot
Screening of Clinically Approved and Investigation Drugs as Potential Inhibitors of SARS-CoV-2 Main Protease and Spike Receptor-Binding Domain Bound with ACE2 COVID19 Target Proteins: A Virtual Drug Repurposing Study
inferred← citeshttps://doi.org/10.26434/chemrxiv.12090426openalex-snapshot
Computational Evaluation of the COVID-19 3c-like Protease Inhibition Mechanism, and Drug Repurposing Screening
inferred← citeshttps://doi.org/10.3233/isb-00268openalex-snapshot
Detailed Comparison of the Protein-Ligand Docking Efficiencies of GOLD, a Commercial Package and ArgusLab, a Licensable Freeware
inferred← citeshttps://doi.org/10.3390/v12040445openalex-snapshot
Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs
inferred← citeshttps://doi.org/10.4172/jcsb.1000007openalex-snapshot
Docking Efficiency Comparison of Surflex, a Commercial Package and Arguslab, a Licensable Freewar
inferred← citeshttps://doi.org/10.5114/bta.2011.46542openalex-snapshot
REVIEW PAPER Virtual screening strategies in drug design – methods and applications
inferred← citeshttps://doi.org/10.5352/jls.2012.22.4.552openalex-snapshot
Expression of SARS-3CL Protease in a Cell-Free Protein Synthesis System
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.